XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
MBLY Mobileye Global
- 17.970
- +0.530+3.04%
Close Feb 14 16:00 ET
- 17.990
- +0.020+0.11%
Post 19:57 ET
14.59BMarket Cap-4.70P/E (TTM)
18.220High17.675Low3.03MVolume17.830Open17.440Pre Close54.36MTurnover3.13%Turnover RatioLossP/E (Static)811.73MShares34.00052wk High1.21P/B1.74BFloat Cap10.48052wk Low--Dividend TTM96.77MShs Float48.110Historical High--Div YieldTTM3.13%Amplitude10.480Historical Low17.955Avg Price1Lot Size
Mobileye Global Key Stats
Quarterly+Annual
YOY
| (FY)Dec 28, 2024 | (Q4)Dec 28, 2024 | (Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 30, 2023 | (Q4)Dec 30, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -20.44%1.65B | -23.08%490M | -8.30%486M | -3.30%439M | -47.82%239M | 11.24%2.08B | 12.74%637M | 17.78%530M | -1.30%454M | 458M |
| Operating revenue | -20.44%1.65B | -23.08%490M | -8.30%486M | -3.30%439M | -47.82%239M | 11.24%2.08B | 12.74%637M | 17.78%530M | -1.30%454M | --458M |
| Cost of revenue | -11.53%913M | -15.02%249M | -3.49%249M | 0.00%230M | -26.29%185M | 8.98%1.03B | 10.57%293M | 10.73%258M | -0.43%230M | 251M |
| Gross profit | -29.23%741M | -29.94%241M | -12.87%237M | -6.70%209M | -73.91%54M | 13.56%1.05B | 14.67%344M | 25.35%272M | -2.18%224M | 207M |
| Operating expense | 17.69%1.27B | 20.66%327M | 32.20%349M | 17.90%303M | 1.39%292M | 12.62%1.08B | -1.81%271M | 9.09%264M | 17.35%257M | 288M |
| Selling and administrative expenses | -1.57%188M | 0.00%46M | 0.00%46M | 2.17%47M | -7.55%49M | 12.35%191M | -11.54%46M | 27.78%46M | 15.00%46M | --53M |
| -Selling and marketing expense | 0.00%118M | 0.00%28M | 0.00%28M | -3.45%28M | 3.03%34M | -1.67%118M | -3.45%28M | 3.70%28M | 0.00%29M | --33M |
| -General and administrative expense | -4.11%70M | 0.00%18M | 0.00%18M | 11.76%19M | -25.00%15M | 46.00%73M | -21.74%18M | 100.00%18M | 54.55%17M | --20M |
| Research and development costs | 21.82%1.08B | 24.89%281M | 38.99%303M | 21.33%256M | 3.40%243M | 12.67%889M | 0.45%225M | 5.83%218M | 17.88%211M | --235M |
| Operating profit | -1,506.06%-530M | -217.81%-86M | -1,500.00%-112M | -184.85%-94M | -193.83%-238M | 10.81%-33M | 204.17%73M | 132.00%8M | -430.00%-33M | -81M |
| Net non-operating interest income expense | 26.53%62M | 63.64%18M | -6.67%14M | -13.33%13M | 112.50%17M | 880.00%49M | 10.00%11M | 400.00%15M | 850.00%15M | 8M |
| Non-operating interest income | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Total other finance cost | -26.53%-62M | -63.64%-18M | 6.67%-14M | 13.33%-13M | -112.50%-17M | -345.45%-49M | -120.00%-11M | -1,400.00%-15M | -275.00%-15M | ---8M |
| Other net income (expense) | -2.7B | 0 | -2.7B | |||||||
| Special income (charges) | ---2.7B | --0 | ---2.7B | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --2.7B | --0 | --2.7B | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Income before tax | -19,868.75%-3.16B | -180.95%-68M | -12,243.48%-2.79B | -350.00%-81M | -202.74%-221M | 150.00%16M | 147.06%84M | 176.67%23M | -325.00%-18M | -73M |
| Income tax | -269.77%-73M | -85.71%3M | -1,400.00%-78M | -50.00%5M | -150.00%-3M | -14.00%43M | 425.00%21M | -60.00%6M | -33.33%10M | 6M |
| Net income | -11,344.44%-3.09B | -212.70%-71M | -16,070.59%-2.72B | -207.14%-86M | -175.95%-218M | 67.07%-27M | 110.00%63M | 137.78%17M | -300.00%-28M | -79M |
| Net income continuous Operations | -11,344.44%-3.09B | -212.70%-71M | -16,070.59%-2.72B | -207.14%-86M | -175.95%-218M | 67.07%-27M | 110.00%63M | 137.78%17M | -300.00%-28M | ---79M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -11,344.44%-3.09B | -212.70%-71M | -16,070.59%-2.72B | -207.14%-86M | -175.95%-218M | 67.07%-27M | 110.00%63M | 137.78%17M | -300.00%-28M | -79M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -11,344.44%-3.09B | -212.70%-71M | -16,070.59%-2.72B | -207.14%-86M | -175.95%-218M | 67.07%-27M | 110.00%63M | 137.78%17M | -300.00%-28M | -79M |
| Basic earnings per share | -12,633.33%-3.82 | -212.50%-0.09 | -16,850.00%-3.35 | -175.00%-0.11 | -170.00%-0.27 | 72.73%-0.03 | 100.00%0.08 | 135.39%0.02 | -354.70%-0.04 | -0.1 |
| Diluted earnings per share | -12,633.33%-3.82 | -212.50%-0.09 | -16,850.00%-3.35 | -175.00%-0.11 | -170.00%-0.27 | 72.73%-0.03 | 100.00%0.08 | 135.39%0.02 | -354.70%-0.04 | -0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?